April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Tesla: Rebound Signals Strength Amid Economic Shifts
3M: Evaluating Challenges to Portfolio Resilience
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Royalty Pharma (RPRX) stock forecast for 2026
Updated: April 21, 2025 (07:12)
Sector: HealthcareThe share price of Royalty Pharma plc (RPRX) now
50/200 Day Moving Average: $32.55 / $28.79
This figure corresponds to the Average Price over the previous 50/200 days. For Royalty Pharma stocks, the 50-day moving average is the resistance level today.
For Royalty Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in Royalty Pharma plc stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Royalty Pharma stock price in 2026. How much will one Royalty Pharma share be worth in 2026? Is it worth taking profit / loss on RPRX stock now or waiting? What are analysts' forecasts for Royalty Pharma stock?
We forecast Royalty Pharma stock performance using neural networks based on historical data on RPRX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Royalty Pharma plc stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Royalty Pharma analysts is $40.03. Today 200 Day Moving Average is the support level (28.79 $). 50 Day Moving Average is the resistance level (32.55 $).
Historical and forecast chart of Royalty Pharma plc stock
The chart below shows the historical price of Royalty Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the RPRX stock price can be found in the table below.
Royalty Pharma plc is a biopharmaceutical royalty purchaser and innovation sponsor for the US biopharmaceutical industry. He is also involved in identifying, evaluating and obtaining royalties for various biopharmaceuticals. In addition, the company partners with innovators from academic institutions, research hospitals and non-profit organizations, small and medium-sized biotech companies, and pharmaceutical companies.
Royalty Pharma (RPRX) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 29.29 | 28.56 | 30.38 | 6.01 % |
| Feb | 27.39 | 26.52 | 27.98 | 5.21 % |
| Mar | 28.35 | 27.06 | 29.70 | 8.89 % |
| Apr | 27.73 | 26.70 | 28.70 | 6.97 % |
| May | 27.60 | 26.30 | 29.06 | 9.50 % |
| Jun | 28.04 | 26.94 | 28.98 | 7.04 % |
| Jul | 29.73 | 28.56 | 31.29 | 8.71 % |
| Aug | 30.25 | 28.55 | 31.43 | 9.16 % |
| Sep | 29.89 | 28.76 | 31.35 | 8.27 % |
| Oct | 30.52 | 29.66 | 31.35 | 5.38 % |
| Nov | 30.49 | 30.07 | 31.65 | 4.99 % |
| Dec | 29.60 | 28.64 | 30.92 | 7.37 % |
Royalty Pharma information and performance
110 EAST 59TH STREET, NEW YORK, NY, US
Market capitalization of the Royalty Pharma plc is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RPRX shares in the company outstanding by the market price of one share.
EBITDA of Royalty Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Royalty Pharma price target for 2026 by month
Target values for the price of one Royalty Pharma share for Jan 2026.
In Jan, the Positive dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 6.007% volatility is expected.
Pessimistic target level: 28.56
Optimistic target level: 30.38
Target values for the price of one Royalty Pharma share for Feb 2026.
In Feb, the Negative dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 5.207% volatility is expected.
Pessimistic target level: 26.52
Optimistic target level: 27.98
Target values for the price of one Royalty Pharma share for Mar 2026.
In Mar, the Positive dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 8.887% volatility is expected.
Pessimistic target level: 27.06
Optimistic target level: 29.70
Target values for the price of one Royalty Pharma share for Apr 2026.
In Apr, the Negative dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 6.966% volatility is expected.
Pessimistic target level: 26.70
Optimistic target level: 28.70
Target values for the price of one Royalty Pharma share for May 2026.
In May, the Negative dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 9.504% volatility is expected.
Pessimistic target level: 26.30
Optimistic target level: 29.06
Target values for the price of one Royalty Pharma share for Jun 2026.
In Jun, the Positive dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 7.043% volatility is expected.
Pessimistic target level: 26.94
Optimistic target level: 28.98
Target values for the price of one Royalty Pharma share for Jul 2026.
In Jul, the Positive dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 8.713% volatility is expected.
Pessimistic target level: 28.56
Optimistic target level: 31.29
Target values for the price of one Royalty Pharma share for Aug 2026.
In Aug, the Positive dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 9.161% volatility is expected.
Pessimistic target level: 28.55
Optimistic target level: 31.43
Target values for the price of one Royalty Pharma share for Sep 2026.
In Sep, the Negative dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 8.275% volatility is expected.
Pessimistic target level: 28.76
Optimistic target level: 31.35
Target values for the price of one Royalty Pharma share for Oct 2026.
In Oct, the Positive dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 5.383% volatility is expected.
Pessimistic target level: 29.66
Optimistic target level: 31.35
Target values for the price of one Royalty Pharma share for Nov 2026.
In Nov, the Negative dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 4.991% volatility is expected.
Pessimistic target level: 30.07
Optimistic target level: 31.65
Target values for the price of one Royalty Pharma share for Dec 2026.
In Dec, the Negative dynamics for Royalty Pharma plc shares will prevail with possible monthly volatility of 7.370% volatility is expected.
Pessimistic target level: 28.64
Optimistic target level: 30.92
Royalty Pharma (RPRX) stock dividend
Royalty Pharma last paid dividends on 02/21/2025. The next scheduled payment will be on 03/10/2025. The amount of dividends is $0.84 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
